Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03790956 · ClinicalTrials.gov registry record · NA
Silk Protein Microparticle-based Filler for Injection Augmentation
A NA study of Dysphonia and Dysphagia, Oropharyngeal, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT03790956 is a NA study of Dysphonia and Dysphagia, Oropharyngeal that has completed, run by University of Southern California. The registered enrollment target is 11 participants, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03790956, a NA study of Dysphonia and Dysphagia, Oropharyngeal, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the safety and efficacy of a silk protein microparticle-based filler for vocal fold injection augmentation to treat dysphonia/dysphagia secondary to vocal fold paralysis. Participants will receive one injection and follow-up for a planned period of 12 months.
Conditions Studied
Interventions
- PROCEDURE Silk Microparticle Filler Injection
Study Locations (1)
California
- University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2023-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03790956
The ClinicalTrials.gov registry entry for NCT03790956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (82% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Dysphonia appearing as the primary indexed condition, and to 1 intervention - of which Silk Microparticle Filler Injection is the first listed.
NCT03790956 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03790956 about?
NCT03790956 is a clinical study titled "Silk Protein Microparticle-based Filler for Injection Augmentation". This study will investigate the safety and efficacy of a silk protein microparticle-based filler for vocal fold injection augmentation to treat dysphonia/dysphagia secondary to vocal fold paralysis. Participants will receive one injection and follow-up for a planned period of 12 months.
What is the current status of trial NCT03790956?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2020-07-01. Estimated completion is 2023-03-15.
What conditions does trial NCT03790956 study?
This clinical trial studies the following conditions: Dysphonia, Dysphagia, Oropharyngeal, Vocal Cord Paralysis Unilateral.
What interventions are being tested in trial NCT03790956?
The interventions under investigation include: Silk Microparticle Filler Injection (PROCEDURE).
Who is sponsoring clinical trial NCT03790956?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03790956 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
RECRUITING · NA
-
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
COMPLETED · NA
-
Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis
COMPLETED · NA
-
Intensive Versus Traditional Voice Therapy
COMPLETED · NA
-
Translaryngeal Vibration for Hyperfunctional Voice Disorders
RECRUITING · Phase 3
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.